Literature DB >> 7008987

Extracorporeal immunoadsorption of myeloma IgG and autoimmune antibodies: a clinically feasible modality of treatment.

P K Ray, E Besa, A Idiculla, J E Rhoads, J G Bassett, D R Cooper.   

Abstract

Using heat-killed, formalin-stabilized Staphylococcus aureus Cowan I suspension, it was possible to remove myeloma IgG and autoimmune anti-red blood cell antibodies from two patients' plasma following an extracorporeal procedure. The arterial anticoagulated blood was processed through a cell separator machine. The separated plasma was pumped through a bacterial filter containing S. aureus suspension. The adsorbed plasma was then reunited with the blood cells and returned to the patient through the vein. S. aureus Cowan I could selectively remove the myeloma IgG and autoimmune anti-red cell antibodies from the patients' plasma prolonging the lives of these two terminal patients. The immunoadsorption procedure appears to be a safe, practical and quick method for the removal of pathological IgG from the patients' plasma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7008987      PMCID: PMC1537095     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  SEROLOGY OF ACQUIRED HEMOLYTIC ANEMIAS.

Authors:  W WEINER; G H VOS
Journal:  Blood       Date:  1963-11       Impact factor: 22.113

2.  Capillary tube testing and enhancement with 30% Albumin.

Authors:  M N Crawford; F E Gottman; L C Rogers
Journal:  Vox Sang       Date:  1976       Impact factor: 2.144

3.  Experience with large volume plasmapheresis in malignant paraproteinaemia and immune disorders.

Authors:  J P Isbister; J C Biggs; R Penny
Journal:  Aust N Z J Med       Date:  1978-04

4.  Plasmapheresis in Goodpasture's syndrome with renal failure.

Authors:  R G Walker; A J d'Apice; G J Becker; P Kincaid-Smith; P W Craswell
Journal:  Med J Aust       Date:  1977-06-11       Impact factor: 7.738

5.  Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.

Authors:  P C Dau; J M Lindstrom; C K Cassel; E H Denys; E E Shev; L E Spitler
Journal:  N Engl J Med       Date:  1977-11-24       Impact factor: 91.245

6.  Intensive plasmapheresis as a therapeutic measure in Rhesus-immunised women.

Authors:  C A Clarke; C J Elson; J Bradley; W T Donohoe; D Lehane; N C Hughes-Jones
Journal:  Lancet       Date:  1970-04-18       Impact factor: 79.321

7.  Immunosuppressive effects of cytosine arabinoside and methotrexate in man.

Authors:  M S Mitchell; M E Wade; R C DeConti; J R Bertino; P Calabresi
Journal:  Ann Intern Med       Date:  1969-03       Impact factor: 25.391

8.  Plasmapheresis in catastrophic complications of idiopathic thrombocytopenic purpura.

Authors:  R Novak; J Wilimas
Journal:  J Pediatr       Date:  1978-03       Impact factor: 4.406

9.  Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus.

Authors:  D S Terman; G Buffaloe; C Mattioli; G Cook; R Tillquist; M Sullivan; J C Ayus
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

10.  Plasma exchange in the treatment of fulminant idiopathic (autoimmune) thrombocytopenic purpura.

Authors:  R F Branda; D Y Tate; J J McCullough; H S Jacob
Journal:  Lancet       Date:  1978-04-01       Impact factor: 79.321

View more
  2 in total

1.  Cysteine Supplementation Mitigates the Toxicity Associated with Antitumor Therapy of Ehrlich's Ascites Fluid Adsorbed over Protein A Containing Staphylococcus aureus Cowan I.

Authors:  Ashish S Verma; Anchal Singh; Priyadarshini Mallick; Premendra D Dwivedi
Journal:  J Pharm Bioallied Sci       Date:  2019 Jan-Mar

2.  Exogenous supplementation of N-acetylcysteine Can Reduce Hepatotoxicity Induced by Ascites Fluid (Cell-Free) Adsorbed Over Protein-A-Containing Staphylococcus aureus Cowan-I Without Compromising Its Antitumor Effect.

Authors:  Ashish S Verma; Priyadarshini Mallick; Premendra D Dwivedi; Anchal Singh
Journal:  J Pharm Bioallied Sci       Date:  2019 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.